John Lauerman, Bloomberg News

John Lauerman is a reporter-at-large at Bloomberg News writing about health and higher education. Lauerman and his colleagues won a Polk Award and were Pulitzer finalists in 2011 for a series of stories on for-profit colleges that recruit low-income students, often to leave them with debt and no degree. The series also won a Gerald Loeb Award, a National Headliner Award, and the Education Writers Association Grand Prize. In 2010, he won a New York Press Club award for coverage of Harvard University’s $1 billion loss on risky investments. He won a 2009 award from the Society of the Silurians for his stories on the failed search for a vaccine against HIV. His team won a 2005 award from the Society of American Business Writers and Editors for coverage of Merck & Co.’s withdrawal of the painkiller Vioxx after it was linked to heart disease. He has been a fellow of the Blue Cross Blue Shield of Massachusetts Health Coverage program and the Kaiser Family Foundation’s program for science journalists.

Before coming to Bloomberg, Lauerman was a science writer at Harvard Medical School from 1985 through 1988. Later, as a freelance journalist, he wrote a health column for Harvard Magazine, contributed to newspapers and magazines across the United States, and edited the public health journal Health and Human Rights. He is the co-author of two books: “Diabetes: Understand Your Condition, Make the Right Treatment Choices, and Cope Effectively,” and “Living to 100.” He lives with his wife and two children in Brookline, Massachusetts.

Read John Lauerman’s latest contributions to The Age of Personalized Medicine Blog